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and Centromere Study
David J. Amor and K. H. Andy Choo
Murdoch Childrens Research Institute, Royal Children’s Hospital, Parkville, Victoria, Australia
The centromere is essential for the proper segregation and inheritance of genetic information. Neocentromeres are
ectopic centromeres that originate occasionally from noncentromeric regions of chromosomes. Despite the complete
absence of normal centromeric a-satellite DNA, human neocentromeres are able to form a primary constriction
and assemble a functional kinetochore. Since the discovery and characterization of the first case of a human
neocentromere in our laboratory a decade ago, 60 examples of constitutional human neocentromeres distributed
widely across the genome have been described. Typically, these are located on marker chromosomes that have been
detected in children with developmental delay or congenital abnormalities. Neocentromeres have also been detected
in at least two types of human cancer and have been experimentally induced in Drosophila. Current evidence from
human and fly studies indicates that neocentromere activity is acquired epigenetically rather than by any alteration
to the DNA sequence. Since human neocentromere formation is generally detrimental to the individual, its biological
value must lie beyond the individual level, such as in karyotype evolution and speciation.
Introduction
Human neocentromeres are new centromeres that ap-
pear in chromosomal locations other than that of the
original centromere. The centromere is of critical im-
portance to chromosome inheritance, with the presence
of one functional centromere per chromosome being an
absolute requirement. The creation of a new centromere
is, therefore, an extraordinary event, with potential im-
plications not only for the chromosome involved but
also for the cell, the organism, and the species.
Centromeres are defined cytogenetically by a con-
striction in the chromosome, generally embedded in
darkly staining heterochromatin. At the center of the
constriction lies the kinetochore, a complex DNA-pro-
tein structure that attaches to microtubules and helps
to direct chromosome movement along the spindle. The
centromeric DNA comprises large numbers of repeat
sequences in tandem arrays. In humans, centromeres
typically contain 2,000–4,000 kb of a 171-bp repeat
known as “a-satellite” (Choo 1997a). Although the re-
peat sequences themselves are poorly conserved across
phylogeny, the presence of satellite DNA at centromeres
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is a feature of virtually all eukaryotic organisms (the
one exception being the budding yeast Saccharomy-
ces cerevisiae). Furthermore, introduction of a-satellite
DNA into cultured cells can result in de novo centro-
mere formation, indicating that the satellite sequence
has a fundamental role in centromere formation (Har-
rington et al. 1997; Ikeno et al. 1998; Henning et al.
1999; Ebersole et al. 2000).
Against this background, the discovery a decade ago
of a human neocentromere that lacked any a-satellite
sequence (Voullaire et al. 1993) was startling and un-
expected. This was a new type of neocentromere, quite
different from the first neocentromeres described in
maize half a century earlier (Rhoades and Vilkomerson
1942) (see the “Maize Knobs: a Different Type of Cen-
tromere” section). The first human neocentromere was
detected on a marker chromosome during the routine
karyotyping of a boy with learning difficulties. This
marker, designated “mardel(10),” was derived from a
de novo complex rearrangement of chromosome 10 that
had resulted in loss of the original centromere. Despite
the complete absence of a-satellite DNA (fig. 1A), the
neocentromere was able to form a primary constriction
and assemble a functional kinetochore that was stable
in mitosis. In the decade following, 60 different con-
stitutional human neocentromeres have been reported,
typically located on rearranged marker chromosomes
that have similarly lost their centromeres. Neocentro-
meres have also been detected in human cancers and
have been produced experimentally in Drosophila.
These cases have provided valuable insight into the
Figure 1 FISH analysis of human neocentric chromosomes. A, Patient cells with a 10q25 neocentromere-containing mardel(10) chro-
mosome (arrow), using pancentromeric a-satellite probe, demonstrating absence of a-satellite (yellow) on the marker chromosome. Image
taken from Voullaire et al. (1993). B, A stable, !2-Mb HAC (arrow) engineered from the mardel(10) chromosome shown in A (Saffery et
al. 2001). Chromosome staining is with DAPI. Image courtesy of L. Wong. C–F, Partial metaphases of well-differentiated liposarcoma cases,
using FISH with a pancentromeric a-satellite probe (C and D) and immunostaining with anticentromere antibody (E and F). Arrows indicate
the supernumerary rings and large rod marker chromosomes. FISH signals (red in C or green in D) with the a-satellite probe are observed
on all chromosomes except the supernumerary ring (C) and large marker (D). Positive staining with the anticentromere antibody (yellow
or green) is observed on all chromosomes including the supernumerary analphoid ring (E) and large marker (F). Images courtesy of F.
Pedeutour and N. Sirvent.
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Figure 2 Sites of formation of constitutional neocentromeres within the human genome. A total of 60 cases, originating from 16 different
human chromosomes, have been described. The mapped positions of each of the neocentromere cases are indicated by bars to the right of the
chromosome ideograms. Longer bars indicate neocentromere sites that have not been precisely localized. Hatch marks on chromosomes 1, 9,
and Y represent blocks of constitutive heterochromatin. Adapted from Choo (2001a).
structure, function, and regulation of neocentromeres,
and they have provided an important model system for
dissecting the function of normal centromeres. A greater
understanding of the properties of neocentromeres has
also opened up new fields of study, such as epigenetic
mechanisms regulating centromere and neocentromere
formation and propagation, the possible role of neo-
centromeres in karyotype and species evolution, and the
use of neocentromere-based artificial chromosomes for
human gene therapy.
Constitutional Human Neocentromeres
Figure 2 and table 1 summarize 60 reported cases of con-
stitutional human neocentromeres in which chromosomal
origin has been investigated. Constitutional human neo-
centromeres are typically analphoid (i.e., they lack de-
tectable a-satellite), are C-band negative, contain a pri-
mary constriction, and, where tested, bind essential
centromere proteins indicative of formation of a func-
tional kinetochore. Most human neocentromeres have
been ascertained either at prenatal diagnosis or by the
cytogenetic analysis of individuals with congenital ab-
normalities, developmental delay, or intellectualdisability.
The formation of a neocentromere is generally as-
sociated with a chromosomal rearrangement, such as
an “inverted duplication” or an interstitial deletion,
which generates a chromosome fragment lacking a con-
ventional centromere (see fig. 3). By far the most com-
mon mechanism for the formation of a neocentric
marker chromosome is the de novo inverted duplication
of a distal chromosome segment (seen in 47 [78%] of
the 60 reported cases; table 1). The resulting marker
comprises two copies of the chromosome segment ori-
ented as a “mirror image” around the breakpoint. Neo-
centromere formation occurs at an interstitial site, be-
tween the breakpoint and one of the telomeres, that is
apparently unrelated to the site of the breakpoint and
unaccompanied by further chromosome rearrangement.
Notably, neocentromere formation occurs only once per
marker chromosome, despite the fact that, in these
cases, the two halves of the marker chromosome consist
of apparently identical DNA sequence. In 13 of these
inverted duplication cases, the marker is accompanied
by a deletion chromosome complementary to the in-
verted duplication, resulting in partial trisomy for the
duplicated region (fig. 3). In the remaining 34 inverted
duplication cases, the karyotype is otherwise normal,
so that the net result is partial tetrasomy for the du-
plicated region (fig. 3). The exact mode of origin of the
partial trisomy and tetrasomy karyotype is unclear, but
various mechanisms have been postulated (fig. 4) (Gard-
ner and Sutherland 1996; Voullaire et al. 2001). In all
of these cases, neocentromere formation clearly has a
detrimental effect on the individual, causing the reten-
tion of a supernumerary chromosome fragment and
therefore creating an unbalanced karyotype.
Interstitial deletions have been responsible for the
generation of neocentric marker chromosomes in nine
cases (table 1). Interstitial deletions are typically asso-
ciated with the formation of a ring chromosome from
either the centric deletion chromosome (in the case of
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Figure 3 Chromosome rearrangements commonly associated with neocentromere formation. Neocentromere formation is typically associated
with a chromosome rearrangement resulting in the generation of a fragment that lacks a conventional centromere. The most common chromosome
rearrangements are interstitial deletions (A and B) and inverted duplications (C and D). Interstitial deletions are typically associated with the
formation of a ring chromosome, which may be necessary to stabilize the broken chromosome ends. The ring chromosome may be derived from
the centric deletion chromosome (in the case of pericentric deletions, shown in A) or from the neocentric fragment (in the case of paracentric
deletions, shown in B). When neocentromere formation results from an interstitial deletion, the resulting karyotype is usually “balanced” at a
cytogenetic level. However, phenotypic effect may result from a “ring syndrome,” leading to mosaicism for one of the fragments, or from interruption
of critical genes at the sites of chromosome breakage or neocentromere formation. Inverted duplications can be supernumerary to the original
karyotype (C) (resulting in tetrasomy for the duplicated segment) or accompanied by a complementary deletion (D) (resulting in trisomy for the
duplicated segment).
pericentric deletions) or the acentric fragment (in the
case of paracentric deletions), allowing the stabilization
of the broken chromosome ends (fig. 3). Meanwhile,
the generation of a neocentromere allows the recovery
of the acentric fragment that would otherwise have been
lost and thereby restores a “balanced” karyotype. In
this circumstance, the formation of the neocentromere
can be said to have “rescued” the cell or individual from
chromosome imbalance, analogous to the “rescue” of
trisomic embryos by the mitotic loss of one copy of a
chromosome from a trisomic embryo. However, phe-
notypic consequences may still arise if the marker is
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Figure 4 Possible mechanisms of formation of neocentric inverted duplication (“inv dup”) marker chromosomes. A, Formation at mitosis.
Chromatid breakage is followed by segregation of the acentric fragment and the centric fragment (or deletion chromosome). Following replication,
the broken sister chromosome ends of the acentric fragment join to form a mirror image inv dup chromosome, with neocentromere formation
occurring on one of the two arms of the inv dup. The centric fragment will usually be lost because of instability; however, stabilization of the
broken end of the fragment will occasionally allow the fragment to survive. Segregation of the inv dup with the centric fragment will lead to
trisomy for the chromosome segment involved, whereas, if the inv dup segregates with two normal chromosome homologues, tetrasomy will
result. B, Formation at meiosis. Formation of an acentric inv dup fragment occurs because of anomalous crossing-over during meiosis I. After
segregation, the dicentric fragment will be lost, but the acentric fragment may be “rescued” by neocentromere formation. After fertilization,
zygotes containing the inv dup will be tetrasomic for the segment involved in the inv dup.
present in mosaic form or if the activities of important
genes residing at the rearrangement breakpoints and/or
the site of neocentromere formation have been com-
promised. Nevertheless, it is possible that similar cases
have not been ascertained because they do not result in
an abnormal phenotype.
Four neocentromere cases cannot be classified as ei-
ther inverted duplications or interstitial deletions. These
comprise one neocentromere situated on a supernu-
merary ring chromosome (Spiegel et al., in press) and
three unusual examples involving the Y chromosome
(Bukvic et al. 1996; Rivera et al. 1996; Tyler-Smith et
al. 1999). In the Y-chromosome cases, the original cen-
tromere is still present but has presumably been inac-
tivated, as a result of either an intrachromosomal re-
arrangement, a reduction in the size of the a-satellite
array, or by other mechanisms. When the neocentric Y
chromosome is mitotically stable, the resulting pheno-
702 Am. J. Hum. Genet. 71:695–714, 2002
type is that of a normal male (Rivera et al. 1996; Tyler-
Smith et al. 1999), but when mitotic instability leads to
mosaicism for the Y chromosome, the result is gonadal
dysgenesis (Bukvic et al. 1996).
Origin and Propagation of Human Neocentromeres
in Mitosis and Meiosis
Understanding of the origin of human neocentromeres
relies on observations in patients in whom the neocen-
tromeres have occurred. DNA polymorphism studies per-
formed in five cases indicate that human neocentromeres
can form either during meiosis (Depinet et al. 1997; Rowe
et al. 2000) or mitosis (Depinet et al. 1997). Once formed,
neocentromeres can be transmitted through mitosis. Mei-
otic transmission has also been demonstrated, most no-
tably by the observation, in two separate families, of a
Y-derived neocentric chromosome in three generations
(Rivera et al. 1996; Tyler-Smith et al. 1999). Transmission
through two generations has also been described for a
marker containing a neocentromere at 3q26 (Wandall et
al. 1998) and for an analphoid marker of unknown origin
(Winters et al. 2000).
Mitotic stability of neocentric marker chromosomes
might be expected to be less than conventional centro-
meres, either due to suboptimal function of the neocen-
tric kinetochore (for which there is no direct evidence
at present) or selection pressure against cells containing
the marker. In addition, ring chromosomes containing
a neocentromere might be lost as part of a “ring syn-
drome,” regardless of the function of the kinetochore
(e.g., because of the formation of mitotically unstable,
interlocking double-ring chromosomes with two active
centromeres). One expected consequence of mitotic in-
stability is the presence of the marker in only a pro-
portion of the patient’s cells (mosaicism), and, in fact,
mosaicism has been observed in more than half of hu-
man neocentric markers (table 1). Mitotic instability is
clearly responsible for the mosaicism observed in neo-
centric markers that have been meiotically transmitted
from the previous generation (Rivera et al. 1996; Tyler-
Smith et al. 1999). However, mosaicism may also result
from the postzygotic formation of a marker that is mi-
totically 100% stable. Alternatively, mosaicism could
arise for a meiotically derived marker if neocentromere
function was not established at the time of meiotic re-
arrangement but developed subsequently after several
postfertilization cell divisions, during which some of the
markers may be lost (Voullaire et al. 2001). A better
measure of mitotic stability of neocentric markers can
be obtained by monitoring the degree of mosaicism at
different points in a patient’s lifetime. Such studies reveal
that the proportion of cells carrying the neocentromere
can either remain stable (Dufke et al. 2001; Voullaire et
al. 2001; Li et al. 2002) or decrease (Rowe et al. 2000)
over time. In one study, in which five separate blood
samples were collected for analysis from a patient over
a period of 13 years, the level of mosaicism of a neo-
centric marker remained relatively unchanged, at 23%–
46% (Voullaire et al. 2001). Subcloning of cultured lym-
phoblast cells from this patient revealed two popula-
tions, one lacking the neocentric marker and the other
containing the marker chromosome that remained
100% stable through 165 cell divisions tested. This ob-
servation suggests that, in some cases, mosaicism is the
result of postzygotic formation of the neocentromere
rather than mitotic instability.
How Are Sites of Neocentromere Formation
Determined?
Human neocentromeres typically form in euchromatic
regions, with the exception of a small number of ex-
amples located in the heterochromatic region of chro-
mosome Yq (fig. 2). However, heterochromatic proteins
such as HP1 and SUV39H1 have been detected at neo-
centromeres formed in euchromatic regions (Aagaard et
al. 2000; Saffery et al. 2000), suggesting that, regardless
of their origins, neocentromeres carry certain character-
istics of heterochromatin. To date, neocentromere for-
mation has been described in 16 of the 22 autosomes
and in the X and Y chromosomes, and there is no reason
to believe that neocentromeres will not eventually be
described on all human chromosomes. A glance at figure
2 reveals some nonrandomness in the distribution of the
reported neocentromeric sites across the human genome,
since those at 3q, 13q, and 15q collectively account for
approximately half of all cases. In addition, distal chro-
mosomal regions appear to be more susceptible to neo-
centromere formation, compared with the more proxi-
mal regions.
How can the distribution of neocentromeres be ex-
plained? One possibility is that neocentromere forma-
tion occurs randomly throughout the genome but that
subsequent selection determines which changes become
stabilized within a cell population. In this scenario, some
putative neocentromere sites (e.g., the more proximal
ones) might result in the formation of marker chro-
mosomes that are not compatible with fetal survival,
either because of their large size or their particular ge-
nomic content. An alternative hypothesis is that genomic
“hotspots” that are favorable to neocentromere for-
mation exist in certain regions of the genome. This hy-
pothesis is supported by the repeated appearance or sig-
nificant clustering of neocentromeres at a number of
chromosomal sites, notably 3q, 8p, 9p, 13q, 15q, and
Yq. It remains to be determined whether this clustering
is due to recurrent neocentromere formation on the same
genetic sequences or the utilization of different DNA
sequences in the same general vicinity.
What characteristics of DNA might favor neocen-
tromere formation? At least the neocentromeres at Yq
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(which consists largely of heterochromatin) may be ex-
plained by the possibility that chromosome regions with
heterochromatic properties are intrinsic sites for neo-
centromere formation (Choo 2001a). Support for this
comes from the demonstration that centromere com-
petence appears to be an innate characteristic of DNA
in heterochromatic blocks (Platero et al. 1999) and that
the heterochromatic state facilitates the binding of the
critical histone H3-related centromere protein CENP-A
in both Drosophila and humans (Henikoff et al. 2000).
The paucity or absence of neocentromere formation at
the heterochromatin on the autosomes may be explained
by the close juxtapositioning of this heterochromatin at
the normal centromeres, which greatly reduces the prob-
ability of their separation from the normal centromeric
domain.
A second and more general possibility is that neocen-
tromere DNA shares some sequence characteristics with
a-satellite DNA, which has been shown to be a preferred
substrate for centromere formation (Harrington et al.
1997; Ikeno et al. 1998). Recently, the CENP-A–binding
domain has been investigated in three different neocen-
tromeres, at 10q25 (Lo et al. 2001a), 20p12 (Lo et al.
2001b), and 9p23 (Satinover et al. 2001a). The three
analyzed domains have been found to range in size from
330 kb to 500 kb, and at the level of the DNA sequence
the only noticeable similarity between the three domains
is an increase in AT content, calculated at 65.4%,
61.1%, and 65%, respectively (compared with the ge-
nome average of 58.0% [Smit 1999] and a-satellite av-
erage of 62.6% [Lo et al. 2001b]). This suggests that
increased AT content may provide a more favorable dis-
position for neocentromere formation. In other respects,
these neocentromere-containing segments show no par-
ticular differences from bulk DNA sequences.
Protein Studies
The activity of neocentromeres is further revealed by
centromere protein-binding studies using specific anti-
bodies. Proteins that associate with mammalian centro-
meres can be broadly classified into two groups on the
basis of their spatial positioning throughout the cell cycle
(Choo 1997a). The first class comprises proteins that are
constitutively associated with the centromere, such as
CENP-A, CENP-B, and CENP-C, which are thought to
have structural roles in kinetochore formation. The sec-
ond class, known as passenger proteins, associate with
the centromere transiently during the cell cycle and com-
prises proteins with diverse roles in cell division, such as
spindle capture, metaphase-to-anaphase transition, and
sister chromatin cohesion. Where analyzed, the neocen-
tromeres have consistently demonstrated the presence
of CENP-A, the centromere-specific core histone that
differentiates the centromere from the rest of the chro-
mosome at the chromatin level, as well as the proteins
CENP-C and CENP-E. However, binding of CENP-B is
consistently absent, a finding that is not unexpected, given
that CENP-B binds specifically toa-satellite repeats (Choo
1997b). Gene-knockout experiments in mice have also
shown that CENP-B is not essential for centromere func-
tion during mitosis and meiosis (Hudson et al. 1998; Ka-
poor et al. 1998; Perez-Castro et al. 1998).
The largest survey has involved the analysis of 120
functionally important kinetochore-associated proteins
in two neocentromeres derived from 10q25 and 20p12
(Saffery et al. 2000). The pattern of protein binding at
the neocentromeres was found to be indistinguishable
from that of the normal centromeres in all respects other
than the absence of binding of CENP-B. This suggests
that neocentromeres assemble a trilaminar kinetochore
and interact with other accessory proteins in a manner
identical to that of normal centromeres, despite the ab-
sence of a-satellite. This conclusion is supported by ev-
idence from electron-microscopy studies demonstrating
that neocentromeres form microtubule-associated kinet-
ochores with size and morphology identical to conven-
tional centromeres (Wandall et al. 1998).
Replication Timing of the Neocentromere Region
Mammalian centromeric regions are known to replicate
at different times during the second half of S phase (Shelby
et al. 2000). Therefore, the timing of replication of neo-
centromere sites, both prior to and after neocentromere
activation, represents an interesting area of study. A de-
tailed analysis has been performed on the 10q25 neocen-
tromere (Lo et al. 2001a). The results demonstrate that,
prior to formation of the neocentromere, this chromo-
somal site replicates at mid-S phase, except for a ∼450-
kb domain containing the CENP-A–binding domain that
replicates duringmid-to-late S phase. After neocentromere
formation, replication timing in this 450-kb region is un-
changed; however, timing is shifted in the areas surround-
ing it. This results in an overall shift of an extended do-
main of 1.5Mb into the third quarter of S phase, bringing
a much larger region covering the core CENP-A–binding
domain into line with the replication timing of all the
other centromeres. This study suggests that the assembly
of a neocentromere drastically alters the overall replica-
tion timing of a genomic region. It also raises the possi-
bility that a microgenomic site with a “centromere-cor-
rect” replication timing may be favorably predisposed to
neocentromere formation (Choo 2001a).
Neocentromere Formation in Human Cancer
Chromosomal abnormalities are a common feature of a
wide variety of neoplastic lesions. Primary chromosome
aberrations are thought to have a causal role in tumori-
genesis and are often specifically associated with partic-
ular tumor types. Secondary aberrations, on the other
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hand, are rarely or never found alone and may not be
causally associated with the development of the cancer.
To date, neocentromere formation has been observed in
only two tumor categories: lipomatous tumors and acute
myeloid leukemia (AML). However, this may underrep-
resent the true extent of neocentromere formation in can-
cer, because solid tumors are relatively infrequently kar-
yotyped. Furthermore, tumors can be particularly difficult
to characterize by chromosome banding techniques, ow-
ing to the complexity of rearrangements, suboptimal
banding quality, and shortage of material. Specific iden-
tification of neocentromeres also requires additional tech-
niques that may not be routinely used in a cytogenetics
laboratory.
Lipomatous Tumors
Lipomatous tumors are a heterogeneous group of neo-
plasms arising from adipose tissue, ranging from benign
lipomas to the highly malignant categories of liposar-
comas (Weiss 1996). Adipocyte tumors of borderline
malignancy are classified as “atypical lipomas and well-
differentiated liposarcomas” (ALP-WDLPS). An appar-
ently primary cytogenetic aberration in these tumors is
the presence of supernumerary marker chromosomes,
either in the form of rings or remarkable “giant rod”–
shaped chromosomes (typically several times the size of
chromosome 1) (Heim et al. 1987; Sreekantaiah et al.
1992; Rosai et al. 1996; Rubin and Fletcher 1997). The
remainder of the karyotype is near-diploid. These rings
and giant rods consistently contain amplification of the
12q14-15 region (including the MDM2 oncogene), as
well as variable interspersed sequences from other chro-
mosomes (Pedeutour et al. 1999).
The centromere properties of rings and giant rods have
been analyzed in 130 cases of ALP-WDLPS (Pedeutour
et al. 1994, 1999; Gisselsson et al. 1998, 1999; Sirvent
et al. 2000; Forus et al. 2001). A constant and specific
feature of these markers is the absence of a-satellite DNA
(fig. 1C–F). However, the rings and giant rods have func-
tional centromeres, as demonstrated by the binding of
centromere proteins (such as CENP-C) and by mitotic
stability. ALP-WDLPS, therefore, represents the first ex-
ample of a tumor class for which the formation of an-
alphoid neocentromeres is a predictable outcome. Neo-
centromere formation presumably provides a mechanism
to impart mitotic stability and, thus, a selective advantage
to the neoplastic cells, on what might otherwise be highly
unstable acentric supernumerary marker chromosomes.
Following stabilization, the neocentric ring chromosomes
could be involved in further structural rearrangements
and gene amplification at mitosis, through breakage-fu-
sion-bridge cycles (Gisselsson et al. 1999). Interestingly,
ring and marker chromosomes containing amplification
of 12q14-15 are also found in the higher-grade forms of
liposarcomas, but these markers typically contain alphoid
centromeres rather than neocentromeres (Gisselsson et al.
1999; Sirvent et al. 2000). Neocentromere formation is,
therefore, not a prerequisite for 12q14-15 amplification.
Conversely, amplification of 12q14-15 may facilitate or
precipitate the formation of the neocentromere. The na-
ture of the DNA sequences involved in the ALP-WDLPS
neocentromeres has yet to be determined, but it is possible
that a site favorable for neocentromere formation is cre-
ated by amplification of 12q14-15. However, it is also
possible that the neocentromere forms on DNA with a
different chromosomal origin, given the feasibility of
neocentromere formation from a wide range of human
genomic sites, as evidenced in constitutional human
neocentromeres. Proper assignment of the chromosomal
origin of the ALP-WDLPS neocentromeres will require
colocalization of neocentromeric sites with defined sub-
chromosomal DNA probes and/or direct molecular iden-
tification of the specific centromere protein-binding DNA
sequences, through use of approaches such as chromatin
immunoprecipitation and genomic array analysis (Lo et
al. 2001a, 2001b).
AML
Neocentromeres have been discovered in the bone
marrow cells of two patients with AML. In the first
case, an analphoid inverted duplication of chromosome
10q (with constriction at 10q26) was found in the bone
marrow of an 18-year-old man with AML (Abeliovich
et al. 1996). The marker was present in 90% of leu-
kemic cells and was associated with an apparently bal-
anced t(11;17). The second neocentric marker was a
mosaic ring chromosome discovered in the complex
karyotype of a 71-year-old man with AML (Gisselsson
et al. 1999). The ring was derived from chromosome
8 but was negative for C-bands and a-satellite, con-
sistent with the presence of a neocentromere. Investi-
gation of the role of neocentromere formation in the
biology of AML will require the ascertainment of ad-
ditional cases containing neocentric markers. However,
existing evidence suggests that, in contrast to lipoma-
tous tumors, neocentromere formation in AML is more
likely to be a secondary chromosome aberration, pos-
sibly resulting from disordered cell-cycle regulation.
Neocentromere Formation in the Laboratory
Neocentromere formation has been successfully induced
in the laboratory fly, providing a useful tool for study
of the underlying mechanism. Neocentromerization in
Drosophila has not been described in the wild but oc-
curred after experimentally inflicted chromosomal re-
arrangement in two separate studies. In the first study,
a subtelomeric chromosome fragment containing a func-
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Figure 5 Generation of neocentromeres in Drosophila. A test segment comprising telomeric heterochromatin and euchromatin forms a
functional neocentromere when released from a site immediately adjacent to a normal centromere (A). One model suggests that centromere
activity or “centromere imprinting factor” spreads from the existing centromere to the neighboring test DNA, where it activates or imparts a
stable centromeric state that can come into independent existence when this DNA is subsequently released. When the same fragment is released
from sites adjacent to pericentromeric heterochromatin (B) or euchromatin (C), a neocentromere does not form.
tional neocentromere was isolated after the irradiation
of a 1.3-Mb minichromosome (g238) derived from the
Drosophila X chromosome (fig. 5A) (Williams et al.
1998). The g238 minichromosome is unusual, in that
290 kb of subtelomeric DNA (on which the neocen-
tromere forms) is translocated next to the 440-kb cen-
tromeric sequence (these entities are normally separated
by 40,000 kb). The juxtaposition of these two elements
is presumably critical to neocentromere formation, be-
cause similar subtelomeric fragments generated from
their normal position on the wild-type X chromosome
do not form neocentromeres in either mitosis or meiosis
(Williams et al. 1998). In follow-up studies, an identical
290-kb segment of DNA was released from various sites
within the Drosophila genome (Maggert and Karpen
2001). Neocentromere formation occurred only when
the segment was released from sites immediately adja-
cent to the centromeric chromatin (similar to the situ-
ation shown in fig. 5A), but not from sites juxtaposed
against pericentromeric heterochromatin or euchroma-
tin (fig. 5B and 5C). These results confirm that activation
of the neocentromere was dependent upon proximity to
an endogenous centromere. Once established, the Dro-
sophila neocentric minichromosome is comparable to
human neocentric chromosomes in that it displays mod-
erately efficient transmission in both meiosis and mitosis
and binds a centromere-specific protein (ZW10) at a
frequency and intensity indistinguishable from normal
Drosophila centromeres.
The second study utilized another variant Dro-
sophila chromosome. This chromosome contains a
megabase-sized insertion of satellite DNA, designated
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Figure 6 Maize knob neocentromeres and the maize karyotype, indicating some of the more common sites of heterochromatic knobs on
the 10 chromosomes (Rhoades 1950). In the presence of a normal chromosome 10 (A), the knobs are inactive and lag behind the normal
centromere at meiosis (inset). When the normal chromosome 10 is replaced by Ab(10), the knobs become neocentromeres. These neocentromeres
bind the spindle microtubules in a lateral rather than an end-on manner and migrate towards the spindle pole in advance of the normal
centromeres that remain active (B). Yellow indicates an active centromere or neocentromere.
“brownDominant” (bwD), near the distal tip of the right
arm of chromosome 2 (Platero et al. 1999). An acen-
tric fragment of this chromosome, containing the bwD
heterochromatic element, was experimentally separated
from its parent chromosome and found to display ef-
ficient centromeric behavior, as determined by forma-
tion of a kinetochore and segregation in mitosis. Cen-
tromeric activity was dependent on the presence of bwD,
leading to the conclusion that bwD can act as a centro-
mere. Furthermore, virtually all fragments containing
bwD displayed centromere activity immediately upon
separation, suggesting that centromeric determinants
are present at all times at bwD.
Recently, neocentromere formation has also been re-
ported in an experimental animal cell culture system.
This occurred during the production of interspecies so-
matic cell hybrids, when a neocentromere was detected
on a fusion chromosome consisting of segments of the
human Y chromosome and mouse chromosomes 12 and
15 (Shen et al. 2001). The fusion chromosome lacked
human a-DNA but contained a neocentromere within
the human Y-derived region. The neocentromere was
unstable in mouse cells but segregated faithfully after
being transferred into chicken DT40 cells.
Maize Knobs: a Different Type of Neocentromere
The term “neocentromere” was first used 60 years ago,
to describe the knob regions of maize chromosomes
(Rhoades and Vilkomerson 1942). Plant neocentromeres
have since been discovered in a number of different species
(Hiatt et al. 2002), but maize knobs remain the most
extensively studied. Knobs are cytologically visible het-
erochromatic regions that can be found at a number of
distinct locations spread across all 10maize chromosomes
(fig. 6A). These regions are composed of thousands of
tandemly repeating DNA sequences, such as the 180- and
350-bp repeats, which share some homology with normal
maize centromeres (Peacock et al. 1981; Ananiev et al.
1998). The knobs are normally inert (i.e., they do not
bind spindle microtubules or aid chromosome segrega-
tion; fig. 6A, inset), but are transformed into neocen-
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tromeres in the presence of a variant of chromosome 10,
known as “Abnormal 10” (Ab10) (fig. 6B). The long arm
of Ab10 has been rearranged such that it contains a large
knob, as well as two neocentromere-activating cassettes
that independently confer neocentromere activity at one
or the other class of knob repeats (Hiatt et al. 2002).
Unlike human neocentromeres, activity of maize neocen-
tromeres is confined to meiosis. During meiosis, they are
bound by the spindle (Rhoades and Vilkomerson 1942;
Rhoades and Dempsey 1966), causing the knobs to move
poleward in advance of the original centromere, which
nonetheless remains active and attaches to spindle micro-
tubules (fig. 6B, inset) (Yu et al. 1997). These chromo-
somes effectively have two or more centromeres, a cir-
cumstance that does not appear to affect the fidelity of
chromosome segregation (Yu et al. 1997). When Ab10 is
present, meiotic drive is observed for Ab10 and for any
other chromosome carrying a knob, so that, on average,
knobbed chromosomes preferentially segregate to 70%
of the viable gametes instead of the expected 50%
(Rhoades 1942). Given this reproductive advantage, the
fact that knobs have not become fixed inmost populations
indicates that knobs must also have deleterious functional
consequences.
The neocentromere phenomenon in maize knobs dif-
fers from that seen in humans in a number of interesting
ways.Most importantly, knob neocentromeres formonly
at the site of large arrays of heterochromatic DNA. In
this respect, knob loci are examples of facultative or ac-
cessory centromeres rather than of neocentromere func-
tion dictated by noncentromeric DNA that normally
serves a totally different function, such as gene coding,
as is the case for most human neocentromere sites. The
activation of knob loci is triggered by a specific cue in
the form of trans-acting factors encoded by Ab10 during
a very specific (meiotic) stage of the organism’s devel-
opmental cycle. No such mechanistic or physiological
drive is known in humans. Furthermore, knob neocen-
tromeres occur despite the presence of a functioning nor-
mal centromere, whereas coexistence of a human neo-
centromere and a functional normal centromere on the
same chromosome has not been described. However, ge-
nomic regions that can facultatively function as centro-
meres are seen in other organisms. For example, in the
horse parasitic nematode Parascaris univalens, the eu-
chromatic and heterochromatic portions of the chro-
mosomes can differentially be used to provide centromere
activity under certain physiological and developmental-
cycle conditions (Goday et al. 1992). Knob neocentro-
meres also behave differently from both normal maize
centromeres and human neocentromeres, in that (1) they
do not form a typical kinetochore (as evidenced by a lack
of binding of the conserved kinetochore proteins CENP-
C, MAD2, and 3F3/2, [Dawe et al. 1999; Yu and Dawe
2000]), and (2) they interact with microtubules in a lat-
eral manner (see fig. 6B, inset), instead of in the end-on
manner typical of the centromeres of maize and all other
organisms (see fig. 6A, inset) (Yu et al. 1997). Knob-
associated neocentromeres, therefore, possess a number
of unusual features that make them an interesting system
for investigation to compare and contrast with conven-
tional centromeres.
Epigenetics and Models for Neocentromere
Generation
So far, we have drawn the following conclusions from
the analysis of neocentromere cases in humans: (1) the
formation of viable neocentric chromosomes is a rare
event; (2) neocentromeres can arise either in mitosis (in-
cluding in cancer) or in meiosis; (3) neocentromeres form
a functional kinetochore and can be stably transmitted
through meiosis and mitosis; (4) neocentromere for-
mation can occur at many different sites across the ge-
nome that do not share a unique DNA sequence but that
may have in common other features that predispose to
neocentromere formation, such as increased AT content;
and (5) the formation of a neocentromere is usually det-
rimental to the individual.
Since the generation of human neocentromeres has
yet to be achieved experimentally, factors controlling
the phenomenon remain largely unknown. Any expla-
nation for how human neocentromeres form and are
propagated to subsequent generations must be inferred
from other sources, such as the study of the function
of normal human centromeres and those in model or-
ganisms. Considerable evidence now exists that gener-
ation and propagation of centromeres is an epigenetic
phenomenon (a heritable change transmitted by mech-
anisms other than that based entirely on DNA se-
quence). For example, studies in yeast have demon-
strated that an inactive centromere can be converted to
an active centromere without change in the content and
structure of DNA and that the active centromere re-
mains active through many generations (Steiner and
Clarke 1994). An analogous human example is found
in the form of pseudodicentric chromosomes, which
contain only one functional centromere, despite the
presence of two separate domains of centromeric DNA.
This demonstrates that the mere presence of centromeric
DNA does not ensure kinetochore formation and func-
tion and that an additional epigenetic factor or “mark”
is required for centromere determination. This epige-
netic mark would act to distinguish centromeric DNA/
chromatin from normal DNA/chromatin and thereby
trigger downstream effects culminating in centromere-
protein acquisition and kinetochore formation. Propa-
gation through cell division would require a strong
“memory,” for the established centromeric chromatin
status to allow the maintenance of the epigenetic mark.
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Figure 7 Formation of human neocentromeres. Human neocentromeres can form in either meiosis or mitosis, by a mechanism that
probably involves the acquisition of a centromere-specific epigenetic mark, followed by formation of a functional kinetochore. Certain chro-
mosomal regions are predisposed to neocentromere formation, possibly because of AT content, heterochromatic qualities, or “centromere-
correct” replication timing. The formation of a marker chromosome containing a neocentromere is dependent on three steps: (1) rearrangement
of the chromosome, generating an acentric fragment (in this example, rearrangement is a paracentric deletion resulting in the formation of a
centric deletion chromosome and a neocentric ring); (2) acquisition of the epigenetic mark required for centromere determination; and (3)
formation of a functional kinetochores. The timing of these events in relation to each other is unclear. It is possible that chromosomerearrangement
is the initial event (path A), followed by acquisition of the epigenetic mark and formation of the kinetochore. Alternatively, the chromosome
arrangement may occur between acquisition of the epigenetic mark and formation of the kinetochore (path B), or, less likely, the chromosome
rearrangement may be consequent to the formation of a functional kinetochore (path C).
The nature of the epigenetic modification and memory
is yet to be determined, but it might involve deposition
of centromere-binding protein (such as CENP-A) that
results in higher-order chromatin reorganization; alter-
natively, it might occur via chemical modification of
centromeric DNA or its associated histones and non-
histone proteins, such as methylation, poly(ADP-ribo-
syl)ation, deacetylation, phosphorylation, and ubiqui-
tination (Choo 2000).
Whatever epigenetic system is utilized by normal cen-
tromeres, it is likely that a closely related mechanism
will apply to neocentromeres. The most convincing ev-
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Figure 8 Evolutionary repositioning of centromeres by neocentromere formation. The initial event in centromere repositioning may be
an impairment of function of the original centromere (B), possibly leading to a reduction of lateral inhibition. A neocentromere may then form
via epigenetic mechanisms not involving alteration to the primary DNA sequence at a favorable site (C). The initial neocentromere may be
imperfect, but, in subsequent generations, selection pressure improves kinetochore maturation through duplication of existing sequence or
accumulation of repetitive DNA from other sources (D–F). The original satellited centromeric DNA would subsequently contract in the absence
of selection pressure and ultimately disappear (D–F).
idence for the epigenetic nature of neocentromerization
in humans comes from extensive analysis of the 10q25
neocentromere, demonstrating that this neocentromere
site is identical to that of the normal chromosome 10
(Lo et al. 2001a; N. Wong, L. Wong, and K. H. A.
Choo, unpublished data). Furthermore, transfection of
YAC clones containing neocentromere DNA from this
region does not produce artificial chromosomes (Saffery
et al. 2001), in contrast to the high frequency of artificial
chromosome formation observed when transfection is
performed using YACs or BACs containing a-satellite
(Harrington et al. 1997; Ikeno et al. 1998; Henning et
al. 1999; Ebersole et al. 2000).
If neocentromere identity is determined by an epi-
genetic mark, how does noncentromeric DNA acquire
this mark? Two models have been proposed to explain
the acquisition of neocentromere activity by noncen-
tromeric DNA. In the first model, centromere activity
spreads from existing centromeric regions to neighbor-
ing DNA, where it imparts a stable centromeric state
(Murphy and Karpen 1998; Williams et al. 1998). This
“activation model” is based on data from the generation
of neocentromeres in the Drosophila g238 minichro-
mosome (fig. 5A) (Williams et al. 1998; Maggert and
Karpen 2001) and predicts that sequences neighboring
an active centromere will be more likely to acquire neo-
centromere activity than sequences elsewhere in the ge-
nome. However, observations in humans suggest that,
if anything, the opposite is true, since human neocen-
tromeres are more often than not formed in distal chro-
mosomal regions. These regions are usually separated
from existing centromeres by vast tracts of DNA that
would prevent any spread of centromeric activity in cis.
Similarly, in the bwD Drosophila model, the hetero-
chromatic block that acquires neocentromeric activity
lies at the opposite end of an ∼20-Mb chromosome arm
from the natural centromere (Platero et al. 1999). It is,
therefore, unlikely that spread of centromeric activity
in cis is a common mechanism for the acquisition of
the epigenetic mark. However, the epigenetic mark for
centromere activity may be able to spread in trans from
an existing centromere. Accordingly, neocentromeres
may arise through the accidental association of nor-
mally noncentromeric DNA with an endogenous cen-
tromere, during centromere templating at meiosis or
mitosis (Maggert and Karpen 2001).
The second model for neocentromere formation (i.e.,
the lateral inhibition model) involves the existence of
many sites along a chromosome that are intrinsical-
ly capable of exhibiting centromere activity but are
normally repressed in cis by the presence of a more
dominant centromere. Such a mechanism might have
evolved to protect against the detrimental effects of mul-
tiple centromeres forming on the same chromosome,
such as dicentric bridges, chromosome breakage, and
aneuploidy. On the basis of this model, neocentromeres
might be expected to form whenever the resident cen-
tromeres are inactivated or deleted. This is consistent
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with observations in the bwD Drosophila model, where
virtually all fragments containing bwD heterochromatic
block display neocentromere activity (Platero et al.
1999). However, if this is also the case in humans, why
are neocentromeres observed so rarely? One possible
explanation is that most human neocentromeres form
in euchromatic regions (other than those in Yq) that
may have a significantly lower affinity for acquisition
of the epigenetic mark. There appears to be a hierar-
chical order of DNA preference for centromere for-
mation, with normal centromeric repeat DNA being the
preferred option, followed by noncentromere hetero-
chromatin (e.g., human Yq and Drosophila bwD), and,
lastly, euchromatic DNA (Choo 2001a). Within these
categories, additional variables are likely to be in play,
such as a preference for DNA adjacent to the centromere
or for euchromatic DNA with an increased AT content
or “correct” DNA-replication time (discussed above, in
the “Constitutional Human Neocentromeres” section).
In this context, a large block of heterochromatin, such
as bwD, may be very likely to form a neocentromere
upon removal of lateral inhibition, because the epige-
netic mark is strong and/or permanently present. The
290-kb neocentromeric fragment from the Drosophila
g238 minichromosome (Williams et al. 1998; Maggert
and Karpen 2001), on the other hand, would require
proximity to the original centromere in order to swing
the balance in favor of consistent neocentromere for-
mation. In the case of human euchromatin, the epige-
netic mark may be only weakly or transiently present,
so that if lateral inhibition is removed by the generation
of an acentric fragment, the probability of a neocen-
tromere forming is increased but remains low. Further-
more, in this circumstance the initial neocentromere
may be less than perfect, requiring a number of cell
divisions to become established. It is also possible that,
in humans, lateral inhibition persists for several cell di-
visions, further reducing the chance that a functional
neocentromere will form (Williams et al. 1998).
These hypotheses are based on the assumption that
the epigenetic mark for neocentromere determination is
acquired prior to or around the time of the chromosome
rearrangement but that the neocentromere does not be-
come functional until after the chromosome rearrange-
ment (fig. 7A and 7B). An alternative theoretical pos-
sibility is that the occasional formation of a functional
neocentromere precedes the loss or inactivation of the
original centromere, such that a functional dicentric
chromosome is created that is subsequently predisposed
to rearrangement (see fig. 7C).
Evolutionary Significance of Neocentromeres
Neocentromere formation in humans is usually detri-
mental to the individual (although, ironically, in at least
one type of cancer, it is advantageous to the cancer cell
population). Fortunately, the stability of the human ge-
nome dictates that such events are rare. In this respect,
neocentromere formation is comparable to other mu-
tations in chromosomes or DNA. If the cost of neocen-
tromere formation is measured in terms of human dis-
ease, what biological function is served by the generation
of neocentromeres? Is it possible that a certain rate of
neocentromere formation, as is generally accepted for
the more familiar types of mutations in chromosomes
or DNA, may be beneficial or even necessary to generate
sufficient genomic variation and diversity for adaptation
during evolutionary time?
Studies in primates indicate that relocation of the cen-
tromere within a chromosome may occur via neocen-
tromere formation (fig. 8). Ventura et al. (2001) have
demonstrated that the X chromosomes of three different
primate species share an identical order of genetic mark-
ers, despite the fact that these X chromosomes have dif-
ferent centromeric locations. The absence of rearrange-
ment on these chromosomes suggests that centromere
repositioning has resulted from the emergence of a new
centromere rather than by translocation of an existing
centromere into this region. More recent examples of
human centromere repositioning “in progress” are sug-
gested by the reports of two separate families in which
a neocentric Y chromosome was transmitted through
three generations (Rivera et al. 1996; Tyler-Smith et al.
1999). These two cases are atypical of constitutional hu-
man neocentromeres, in that centromere function is pro-
vided by an analphoid neocentromere at the expense of
the inactivation and retention of the original a-satel-
lite–containing centromere on an otherwise intactY chro-
mosome. Individuals with such neocentric Y chromo-
somes are phenotypically normal and fertile, indicating
that the neocentromere is functioning in mitosis andmei-
osis. According to one model, an initial rearrangement
or reduction in size of the a-satellite DNA array may
remove kinetochore binding capacity in an amount suf-
ficient to impair centromere function, allowing the emer-
gence or activation of a neocentromere (Tyler-Smith et
al. 1998). The initial neocentromere is imperfect, but, in
subsequent generations, selection pressure improves ki-
netochore maturation through duplication of existing se-
quence or accumulation of repetitive DNA from other
sources. The original a-satellite centromeric DNAwould
subsequently contract in the absence of selection pressure
and would ultimately disappear (fig. 8). In evolutionary
terms, centromere relocation would rapidly lead to the
reproductive isolation of emerging species, providing a
formidable mechanism for speciation (Henikoff et al.
2001).
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Human Artificial Chromosomes: a Therapeutic Role
for the Neocentromere?
It is possible that human neocentromeres may provide
new opportunity for disease treatment, in the form of
neocentromere-based human artificial chromosomes
(HACs) for use as vectors in gene therapy. Compared
with other gene-delivery vectors, HAC-based systems are
able to carry DNA segments of very large size and are
unlikely to be immunogenic. HACs also avoid the un-
predictable genomic events associated with random in-
tegration. All potential artificial chromosomes require
an active centromere to ensure faithful mitotic segre-
gation. Most HACs utilize a-satellite DNA centromeres,
but neocentromere-based HACs, generated by telomere-
associated truncation of neocentric chromosomes de-
rived from human subjects (fig. 1B) (Saffery et al. 2001),
may provide a viable alternative. Potential advantages
of neocentromere-based HACs include the fact that they
are fully definable in terms of DNA sequence, and they
may prove to be significantly smaller and to provide a
more suitable environment for expression of introduced
therapeutic genes, compared with HACs containing a-
satellite (Choo 2001b; Saffery and Choo 2002).
Concluding Remarks
The first decade of human neocentromere research has
provided a taste for the involvement of neocentromeres
in human health, disease, and evolution. It has directly
unveiled the incredibly malleable nature of not only the
centromeric, but also the wider genomic, chromatin.
Much excitement and debate has been generated over the
possible mechanisms that are responsible for the forma-
tion and propagation of the neocentromeres—mecha-
nisms that are likely to be inseparably linked to those that
underlie the typical centromeres. Further studies should
now be focused on identifying these mechanisms and
should capitalize on the fully known sequences of neo-
centromeres to study the properties of the centromeres.
On the basis of the varied spectrum of information we
have gained to date from studying neocentromeres in fly,
plant, lower primates, and humans, the further definition
of the true extent of the neocentromere phenomenon in
these and other species should be quite informative. If the
first decade has laid some useful foundation for this phe-
nomenon, the next decade should see its expansion into
a fuller understanding of centromere biology and, pos-
sibly, improved health outcomes.
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